Exhibit 99.9

Exception Grades

Run Date - 5/20/2026 8:52:15 AM

SitusAMC Loan ID Customer Loan ID Seller Loan ID Investor Loan Number Loan Exception ID Exception ID Exception Date Exception Type Exception Category Exception Subcategory 15E Category Exception Exception Detail Exception Information Compensating Factors Compensating Factor Information Applying Party Follow-up Comments Cleared Date Cured Date Waived Date Exception Level Grade DBRS Initial Exception Rating DBRS Final Exception Rating Fitch Initial Exception Rating Fitch Final Exception Rating Kroll Initial Exception Rating Kroll Final Exception Rating Moody's Initial Exception Rating Moody's Final Exception Rating S&P Initial Exception Rating S&P Final Exception Rating Note Date Property State Occupancy Purpose Exception Remediation Overall
Initial Loan Grade		 Overall
Final Loan Grade		 Credit
Initial Loan Grade		 Credit
Final Loan Grade		 Compliance
Initial Loan Grade		 Compliance
Final Loan Grade		 Property
Initial Loan Grade		 Property
Final Loan Grade		 Originator QM ATR Status TPR QM ATR Status Is Curable
225541931   3158625727   36397460     Compliance Compliance Federal Compliance TRID Defect TRID Final Closing Disclosure Finance Charge Test TILA-RESPA Integrated Disclosure - Loan Calculations: Final Closing Disclosure provided on [Redacted] disclosed an inaccurate Finance Charge on page 5 that does not match the actual Finance Charge for the loan. The disclosed Finance Charge in the amount of $[Redacted] is under disclosed by $[Redacted] compared to the calculated Finance Charge of $[Redacted] which exceeds the $[Redacted] threshold.  Disclosed Amount Financed on page 5 is also blank or inaccurate.  Fee amounts included in Finance Charge and Amount Financed calculations are based on Closing Disclosure dated [Redacted]). The disclosed Finance Charge in the amount of
$[Redacted] is under disclosed by $[Redacted]
compared to the calculated Finance Charge of
$[Redacted] which exceeds the $[Redacted]
threshold.		       Reviewer Comment (2026-05-18): [Redacted] received Letter of Explanation, Proof of Delivery, Refund check & Corrected CD


Buyer Comment (2026-05-15): Please see PCCD and Refund sent to the borrower


Reviewer Comment (2026-05-13): 1026.4(c)(7) indicates the following fees may be excluded from APR calculations.
(i) Fees for title examination, abstract of title, title insurance, property survey, and similar purposes.
(ii) Fees for preparing loan-related documents, such as deeds, mortgages, and reconveyance or settlement documents.
(iii) Notary and credit-report fees.
(iv) Property appraisal fees or fees for inspections to assess the value or condition of the property if the service is performed prior to closing, including fees related to pest-infestation or flood-hazard determinations.
(v) Amounts required to be paid into escrow or trustee accounts if the amounts would not otherwise be included in the finance charge.
Neither the Additional Work Charge, nor the Concurrent Loan Services fee would fall into the above exclusions based on the fee purpose description provided by the title company. Barring further fee purpose documentation being presented, the finance charge exception appears valid and requires a cure.


Buyer Comment (2026-05-12): Please see e-mail response from the title company regarding fees.
   05/18/2026   2 C B C B C B C B C B   CA Primary Purchase TILA Material Disclosure Cure - Provide the following: Letter of Explanation, Proof of Delivery, Refund check for underdisclosed amount, Corrected CD, and Re-open Rescission (required on rescindable transactions) C B A A C B A A Safe Harbor QM (APOR) Safe Harbor QM (APOR) Yes
225541931   3158625727   36425770     Compliance Compliance Federal Compliance TRID TRID Ten Percent Tolerance Violation With Sufficient Cure Provided At Closing TILA-RESPA Integrated Disclosure: Ten Percent
Fee Tolerance exceeded. Total amount of
$[Redacted] exceeds tolerance of $[Redacted]
plus [Redacted]% or $[Redacted].  Sufficient or
excess cure was provided to the borrower at
Closing.		         Reviewer Comment (2026-05-08): Sufficient Cure
Provided At Closing
   05/08/2026   1 A A A A A A A A A A   CA Primary Purchase Final CD evidences Cure C B A A C B A A Safe Harbor QM (APOR) Safe Harbor QM (APOR) Yes
225541933   3158625849   36394288     Compliance Compliance Federal Compliance TRID TRID Ten Percent Tolerance Violation With Sufficient Cure Provided At Closing TILA-RESPA Integrated Disclosure: Ten Percent Fee Tolerance exceeded. Total amount of $[Redacted] exceeds tolerance of $[Redacted] plus [Redacted]% or $[Redacted].  Sufficient or excess cure was provided to the borrower at Closing.         Reviewer Comment (2026-05-04): Sufficient Cure Provided At Closing
   05/04/2026   1 A A A A A A A A A A   VA Primary Purchase Final CD evidences Cure A A A A A A A A Safe Harbor QM (APOR) Safe Harbor QM (APOR) Yes
225541936   3158625939   36392687     Compliance Compliance Federal Compliance TRID Defect TRID Ten Percent Tolerance Violation Without Sufficient Cure Provided TILA-RESPA Integrated Disclosure: Ten Percent Fee Tolerance exceeded. Total amount of $[Redacted] exceeds tolerance of $[Redacted] plus [Redacted]% or $[Redacted].  $[Redacted] over legal limit.  Insufficient or no cure was provided to the borrower. Ten Percent Fee Tolerance exceeded. Total amount of $[Redacted] exceeds tolerance of $[Redacted] plus [Redacted]% or $[Redacted].  $[Redacted] over legal limit.  No valid change of circumstance found in file and no evidence of a tolerance cure.       Reviewer Comment (2026-05-12): [Redacted] received COC dated [Redacted].


Buyer Comment (2026-05-08): Do Not Concur please review CIC
 05/12/2026     1 C A C A C A C A C A   MD Primary Purchase Fee Tolerance Refund Provide the
Following: Letter of Explanation, Proof of
Delivery, Copy of Refund Check, and
Corrected CD		 C A A A C A A A Safe Harbor QM (APOR) Safe Harbor QM (APOR) Yes